Total ghrelin levels are increased in CKD patients, as ghrelin is mainly degraded by kidneys; however, this increase associates with an increase in obestatin and desacyl forms of ghrelin, which may induce effects that are opposite to those of the active orexigenic form of ghrelin, i.e., acyl ghrelin, thus decreasing appetite. This evidence concerns the gene GHRL and chronic kidney disease.